Enterprise Value
1.135B
Cash
311.1M
Avg Qtr Burn
-59.99M
Short % of Float
21.61%
Insider Ownership
8.63%
Institutional Own.
90.02%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SC291 (CD19) Details B-cell malignancies | Phase 1 Data readout | |
SC262 Details B-cell malignancies | Phase 1 Data readout | |
SC291 (CD19) Details Lupus nephritis, ANCA-Associated Vasculitis | Phase 1 Data readout | |
UP421 Details Type 1 diabetes | Phase 1 Update |